CHEMOTHERAPY OF ESOPHAGEAL CANCERS - EFFECT OF THE VINDESINE-CISPLATINUM-BLEOMYCIN ASSOCIATION

被引：0
|
作者：
BOURRY, J [1 ]
KHATER, R [1 ]
BOUBLIL, JL [1 ]
GIACOMINI, MA [1 ]
NAMER, M [1 ]
机构：
[1] CTR ANTOINE LACASSAGNE,F-06054 NICE,FRANCE
来源：
BULLETIN DU CANCER | 1985年 / 72卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [41] SUCCESSFUL COMBINATION CHEMOTHERAPY (CISPLATINUM, VINBLASTINE, AND BLEOMYCIN) IN THE TREATMENT OF MEDULLOBLASTOMA DISSEMINATED BY CEREBROSPINAL-FLUID - CASE-REPORT
    ASAI, A
    MATSUTANI, M
    KOHNO, T
    FUJIMAKI, T
    TAKAKURA, K
    NEUROSURGERY, 1989, 24 (03) : 439 - 443
  • [42] EFFECTIVE CHEMOTHERAPY FOR ESOPHAGEAL CANCER WITH METHOTREXATE, BLEOMYCIN, AND CIS-DIAMMINEDICHLOROPLATINUM(II)
    VOGL, SE
    GREENWALD, E
    KAPLAN, BH
    CANCER, 1981, 48 (12) : 2555 - 2558
  • [43] THE CLINICAL IMPACT OF SARCOPENIA ON CHEMOTHERAPY DELIVERY FOR GASTRIC AND ESOPHAGEAL CANCERS
    Geddes, K.
    Rouse, H.
    McLachlan, S-A
    Sundararajan, V.
    Moore, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 55 - 55
  • [44] Association of esophageal adenocarcinoma with other subsequent primary cancers
    Das, Ananya
    Thomas, Sapna
    Zablotska, Lydia B.
    Neugut, Alfred I.
    Chak, Amitabh
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (05) : 405 - 411
  • [45] VINDESINE, CISPLATIN, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER - SURVIVAL AND QUALITY-OF-LIFE
    BAKKER, W
    VANOOSTEROM, AT
    AARONSON, NK
    VANBREUKELEN, FJM
    BINS, MC
    HERMANS, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 963 - 970
  • [46] Second-line chemotherapy with bleomycin vindesine (eldesine(R)) mitomycin-C (BEM) in cervical cancer (CC) patients
    Vermorken, JB
    DeOliveira, CF
    Panici, PB
    Lacave, A
    Huinink, WWT
    Teodorovic, I
    Colombo, N
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1189 - 1189
  • [47] CHEMOTHERAPY OF SQUAMOUS HEAD AND NECK-CANCER - A PROSPECTIVE RANDOMIZED TRIAL COMPARING CIS-PLATINUM AND BLEOMYCIN WITH METHOTREXATE AND VINDESINE
    VONHEYDEN, HW
    SCHRODER, M
    SCHERPE, A
    BORGHARDT, J
    BEYER, JH
    NAGEL, GA
    GERHARTZ, H
    FOTH, B
    KASTENBAUER, E
    WESTERHAUSEN, M
    CALIEBE, W
    RUDERT, H
    LIFFERS, R
    HOFMANN, J
    SCHNEIDER, B
    RECENT RESULTS IN CANCER RESEARCH, 1985, 98 : 148 - 152
  • [48] INDUCTION CHEMOTHERAPY IN HEAD AND NECK-CANCER WITH CISPLATINUM (C), 5 FLUORO URACIL (F), BLEOMYCIN (B) OR C+
    BASSOT, F
    BRASNU, D
    STGUILLY, L
    MENARD, M
    FABRE, A
    DONNADIEU, S
    LACCOURREYE, H
    JACQUILLAT, C
    CANCER DRUG DELIVERY, 1986, 3 (01): : 60 - 60
  • [49] SAFE USE OF ADJUVANT REGIONAL CHEMOTHERAPY WITH CONCOMITANT MAJOR RESECTIONS OF EXTREMITY CANCERS - A NEW ROLE FOR CISPLATINUM AND ETOPOSIDE
    ROSEMAN, JM
    SOUTHERN MEDICAL JOURNAL, 1986, 79 (09) : 77 - 77
  • [50] SAFE USE OF ADJUVANT REGIONAL CHEMOTHERAPY WITH CONCOMITANT MAJOR RESECTIONS OF EXTREMITY CANCERS - A NEW ROLE FOR CISPLATINUM AND ETOPOSIDE
    ROSEMAN, JM
    CANCER DRUG DELIVERY, 1986, 3 (01): : 88 - 88
12345